Table 1 Baseline characteristics and demographical features of the study population
Variables | sinus rhythm (n = 78) | AF recurrence (n = 47) | P value |
|---|---|---|---|
Age (years) | 61.5 (13.25) | 63.0 (15.0) | 0.717 |
Gender (female) | 38 (48.7%) | 18 (38.3%) | 0.256 |
Body mass index (kg/m2) | 24.7 ± 2.9 | 26.1 ± 3.1 | 0.016* |
Hypertension | 47 (60.3%) | 34 (72.3%) | 0.171 |
Diabetes mellitus | 9 (11.5%) | 14 (29.8%) | 0.011* |
Coronary artery disease | 19 (24.4%) | 9 (19.1%) | 0.499 |
Stroke | 13 (16.7%) | 8 (17.0%) | 0.959 |
AF duration (months) | 12.0 (31.25) | 24.0 (48.0) | 0.035* |
Procedure time (minnutes) | 240 (60.0) | 240 (119.0) | 0.969 |
CHA2DS2-VASc score | 2.0 (2.0) | 2.0 (2.0) | 0.172 |
HATCH score | 0.95 ± 0.89 | 1.09 ± 0.93 | 0.418 |
Hemoglobin (g/L) | 137.9 ± 21.6 | 137.1 ± 16.2 | 0.847 |
AST (U/L) | 21 (10.25) | 23 (8.0) | 0.578 |
Serum creatinine (umol/L) | 83.0 ± 18.3 | 86.6 ± 19.1 | 0.301 |
Uric acid (umol/L) | 309.3 ± 84.5 | 325.2 ± 96.4 | 0.336 |
WBC (×109/L) | 5.40 (1.91) | 5.69 (2.35) | 0.359 |
Monocyte (× 109/L) | 0.32 (0.13) | 0.35 (0.15) | 0.007* |
LDL cholesterol (mmol/L) | 2.42 (1.18) | 2.36 (0.88) | 0.521 |
HDL cholesterol (mmol/L) | 1.33 (0.54) | 1.09 (0.40) | 0.002* |
Monocyte/HDL ratio | 6.34 (3.39) | 8.29 (4.99) | 0.000* |
Cystatin C (mg/L) | 0.8 (0.39) | 0.8 (0.30) | 0.165 |
D-Dimer (mg/L) | 0.27 (0.21) | 0.27 (0.14) | 0.008* |
LAD (mm) | 34 (6.0) | 38 (6.0) | 0.000* |
LVEF (%) | 62 (1.25) | 61 (3.0) | 0.205 |
Follow-up duration (months) | 22 (20.25) | 19 (12.0) | 0.165 |